glp-1 substance use disorder Glucagon-like peptide-1 receptor agonists and risk of disorders among US veterans with type 2 diabetes: cohort study How Can GLP-1 Agonists Be

sleep apnea (concomitant obesity but not T2D)

Wondering about GLP-1 dosing approaches

GLP-1 medications have also been associated with: Worsening of diabetic retinopathy Exacerbation of age-related macular degeneration Optic nerve complications, including NAION These risks dont mean you should stop taking your medication, but they do show why its important to have an eye exam before starting and regular follow-up exams while on treatment

Most patients tolerate mild-to-moderate reflux with dietary modification and antacid use for 3-7 days before symptoms improve naturally

Because different GLP-1 agonists have different FDA-labeled indications, they may be used for different reasons, such as type 2 diabetes or weight loss

Adding peptide therapy or testosterone optimization can further support muscle growth in appropriate candidates